Project Grant K99HG013675
Award Date
9/23/24
Completion Date
8/31/26
Dollars Obligated
$137K
Federal Agency
National Human Genome Research Institute
Federal Grant Program
93.172
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
The National Human Genome Research Institute (NHGRI) awarded a $1,350,896 Project Grant under the Human Genome Research program (CFDA 93.172) to the University of California, San Diego (UCSD) effective January 1, 2025 through December 31, 2028. The overarching goal of this research project is to develop novel technology based on massively parallel reporter barcoding strategies to enable simultaneous measurements of the effects of sequence perturbations on chromatin state, DNA-protein...
This $588,426 Project Grant award, provided by the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), aims to investigate how transcription factors efficiently locate and bind to specific DNA binding sites within the crowded nucleus of living cells. The project will employ advanced microscopy techniques to precisely track the 3D diffusion, DNA interactions, and target site discrimination of transcription factors involved in...
This $1,273,296 Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) supports research to develop advanced models for predicting the impact of genetic variants on mRNA stability, translation, and protein levels. The key products and services to be delivered include: High-throughput reporter assays to characterize how variants in coding and untranslated regions impact mRNA stability and translation, including across multiple cell types....
This $400,000 Project Grant award from the National Human Genome Research Institute (NHGRI) under CFDA 93.172 "Human Genome Research" will support a research program at Brigham & Women's Hospital to develop advanced computational methods for accurately identifying and genotyping structural variants within large genetic biobank datasets. The key objectives of the work are to: 1) create haplotype-informed algorithms to improve detection sensitivity and genotyping accuracy for...
This Project Grant award of $1,038,898.88 from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) supports research to develop novel approaches for integrating single-cell data with genome-wide association studies (GWAS) to elucidate the genetic architecture of complex diseases. The key products and services to be delivered under this 5-year award include: Identifying novel disease-relevant cell states by leveraging single-cell epigenetic data Utilizing...
This $292,727 Project Grant award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) supports a research project by The Broad Institute, Inc. to discover novel regulators of 3D genome organization. The project aims to leverage large-scale genomic datasets to predict and experimentally validate new trans-acting factors that regulate chromatin interactions and genome architecture. By applying deep neural network models to in silico genetic...
This Project Grant award, valued at $491,366, was issued by the National Human Genome Research Institute (NHGRI) under the Human Genome Research federal grant program (CFDA 93.172). The award is focused on developing new algorithms to robustly map disease-associated genetic variants to critical target genes, particularly in underrepresented populations. Key objectives include: Improving the ability to identify disease-critical genes in non-European populations where data is limited. Developing...
This federal Project Grant award of $142,065 from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) supports the development of computational frameworks to model the impact of external signals on a cell's internal transcription factor activity. The key products and services to be delivered under this award include: Computational methods to more accurately deconvolve cell type fractions and gene expression from bulk RNA-seq and spatial transcriptomics data. A...
This $390,000 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) will support the development of innovative proteomic technologies to study transcription factor-coregulator interactions. The award aims to pioneer DNA barcode-based methods that can enhance the specificity and reproducibility of existing techniques like mass spectrometry-based RIME for characterizing epigenetic...
Brigham & Women's Hospital Inc. was awarded a $300,000 Project Grant from the National Human Genome Research Institute (CFDA 93.172 Human Genome Research) to develop computational and experimental approaches to better stratify the risk of rare genetic variants associated with monogenic diseases. The project aims to leverage large disease cohorts and national biobanks, along with cost-effective variant assays, to integrate clinical phenotyping data and functional assessment to improve the...